GB1472534A - 7beta-hydroxyiminoacylamido-cephalosporins - Google Patents

7beta-hydroxyiminoacylamido-cephalosporins

Info

Publication number
GB1472534A
GB1472534A GB3227373A GB3227373A GB1472534A GB 1472534 A GB1472534 A GB 1472534A GB 3227373 A GB3227373 A GB 3227373A GB 3227373 A GB3227373 A GB 3227373A GB 1472534 A GB1472534 A GB 1472534A
Authority
GB
United Kingdom
Prior art keywords
hydroxyiminoacylamido
7beta
cephalosporins
july
brn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3227373A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB3227373A priority Critical patent/GB1472534A/en
Priority to US05/485,233 priority patent/US4007174A/en
Priority to AU70723/74A priority patent/AU492244B2/en
Priority to LU70477A priority patent/LU70477A1/xx
Priority to AT556074A priority patent/AT335061B/de
Priority to DE2432415A priority patent/DE2432415A1/de
Priority to BE146263A priority patent/BE817304A/xx
Priority to IE1436/74A priority patent/IE39595B1/xx
Priority to FR7423534A priority patent/FR2235696B1/fr
Priority to ES428015A priority patent/ES428015A1/es
Priority to NL7409179A priority patent/NL7409179A/xx
Priority to CA204,132A priority patent/CA1055016A/en
Priority to ZA00744349A priority patent/ZA744349B/xx
Priority to CH927374A priority patent/CH615436A5/de
Priority to DK360874A priority patent/DK360874A/da
Priority to JP49077193A priority patent/JPS5069093A/ja
Priority to SE7408892A priority patent/SE7408892L/xx
Priority to US05/746,596 priority patent/US4076936A/en
Publication of GB1472534A publication Critical patent/GB1472534A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
GB3227373A 1973-07-06 1973-07-06 7beta-hydroxyiminoacylamido-cephalosporins Expired GB1472534A (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB3227373A GB1472534A (en) 1973-07-06 1973-07-06 7beta-hydroxyiminoacylamido-cephalosporins
US05/485,233 US4007174A (en) 1973-07-06 1974-07-01 Cephalosporin compounds
AU70723/74A AU492244B2 (en) 1974-07-02 Improvements in or relating to antibiotics
LU70477A LU70477A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-07-06 1974-07-05
AT556074A AT335061B (de) 1973-07-06 1974-07-05 Verfahren zur herstellung von neuen cephalosporinen
DE2432415A DE2432415A1 (de) 1973-07-06 1974-07-05 Antibiotica
BE146263A BE817304A (fr) 1973-07-06 1974-07-05 Acides cepheme-carboxyliques a groupe 7 alpha-alcoxy inferieur
IE1436/74A IE39595B1 (en) 1973-07-06 1974-07-05 7 -hydroxyiminoacylamidocephalosporins
FR7423534A FR2235696B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-07-06 1974-07-05
ES428015A ES428015A1 (es) 1973-07-06 1974-07-05 Un procedimiento para la preparacion de un compuesto anti- biotico de la serie de la cefalosporina.
NL7409179A NL7409179A (nl) 1973-07-06 1974-07-05 Werkwijze voor de bereiding van cefalosporine- derivaten.
CA204,132A CA1055016A (en) 1973-07-06 1974-07-05 7.alpha.-LOWER ALKOXY-7.beta.-(2-ARYL-2-HYDROXYIMINOACETAMIDO) CEPH-3-EM-4-CARBOXYLIC ACIDS
ZA00744349A ZA744349B (en) 1973-07-06 1974-07-05 Improvements in or relating to antibiotics
CH927374A CH615436A5 (en) 1973-07-06 1974-07-05 Process for the preparation of the syn-isomer or of a mixture of syn- and anti-isomers of novel 7-alpha-substituted 7-beta-acylaminoceph-3-em-4-carboxylic acids
DK360874A DK360874A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-07-06 1974-07-05
JP49077193A JPS5069093A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-07-06 1974-07-05
SE7408892A SE7408892L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-07-06 1974-07-05
US05/746,596 US4076936A (en) 1973-07-06 1976-12-01 7β-(2-Aryl-2-hydroxyiminoacetamido)ceph-3-em-4-carboxylic acids carrying a 7α-lower alkoxy substituent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3227373A GB1472534A (en) 1973-07-06 1973-07-06 7beta-hydroxyiminoacylamido-cephalosporins

Publications (1)

Publication Number Publication Date
GB1472534A true GB1472534A (en) 1977-05-04

Family

ID=10336049

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3227373A Expired GB1472534A (en) 1973-07-06 1973-07-06 7beta-hydroxyiminoacylamido-cephalosporins

Country Status (16)

Country Link
US (1) US4007174A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5069093A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT335061B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE817304A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1055016A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH615436A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2432415A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK360874A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES428015A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2235696B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1472534A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE39595B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU70477A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7409179A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE7408892L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA744349B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092477A (en) * 1971-05-14 1978-05-30 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4165429A (en) * 1976-06-28 1979-08-21 Yamanouchi Pharmaceutical Co., Ltd. 7α-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES
GB1592149A (en) * 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1648407A4 (en) * 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
CA2533358C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
WO2005016278A2 (en) * 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
US8460710B2 (en) * 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp IMPROVED ABSORPTION OF DOSAGE FORMS WITH MODIFIED RELEASE
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE311519B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1962-12-14 1969-06-16 Astra Ab
GB1208015A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
US3573294A (en) * 1968-03-14 1971-03-30 Glaxo Lab Ltd 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
GB1433141A (en) * 1972-07-07 1976-04-22 Glaxo Lab Ltd Antibiotics
GB1389194A (en) * 1971-01-29 1975-04-03 Glaxo Lab Ltd Antibiotics

Also Published As

Publication number Publication date
FR2235696B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-12-24
CH615436A5 (en) 1980-01-31
JPS5069093A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-06-09
US4007174A (en) 1977-02-08
SE7408892L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-01-07
ATA556074A (de) 1976-06-15
FR2235696A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-01-31
ZA744349B (en) 1975-07-30
DK360874A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-03-03
NL7409179A (nl) 1975-01-08
AU7072374A (en) 1976-01-08
IE39595B1 (en) 1978-11-22
ES428015A1 (es) 1976-07-16
BE817304A (fr) 1975-01-06
DE2432415A1 (de) 1975-01-30
IE39595L (en) 1975-01-06
CA1055016A (en) 1979-05-22
LU70477A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-05-31
AT335061B (de) 1977-02-25

Similar Documents

Publication Publication Date Title
GB1472534A (en) 7beta-hydroxyiminoacylamido-cephalosporins
GB1132083A (en) A novel thymine derivative and a process for the preparation thereof
GB1333317A (en) Substituted glutaronitriles as antijungal agents
GB1385342A (en) Ligand determination of spin labelled compounds by receptor displacement
GB1373463A (en) 4-tetrazol-5-yl- butyltripenhylphosphonium bromide
GB1140986A (en) New basic monoazo dyestuffs and processes for their manufacture
GB1258026A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB1426170A (en) Selenium-75 derivatives of steroids
GB1191808A (en) Preparation of Streptozotocin
GB1419631A (en) Bonding process
GB1292737A (en) Haloepoxides
GB1295685A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB1425409A (en) Radiation-sensitive polymers and their use
GB1174907A (en) Improvements in or relating to Silver Halide Photography
GB1259177A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB1173680A (en) Heterocyclic Isocyanates
GB1435243A (en) Ketimine derivatives and process for their production
GB1165914A (en) Salts of Perfluorocyclo Alkanols
GB1420777A (en) Coumarin and coumarinimide compounds
GB1409993A (en) Antitussive
GB1330609A (en) 4-n-lower alkanoyl hydroxylamino 4- aminodiphenylsulphone compounds
GB1349467A (en) Transportation and delivery of concrete
GB1165926A (en) 2-Amino-4-Phenoxypyrimidines
GB1132783A (en) Acaricides
GB1257750A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee